DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: OCREVUS (ocrelizumab)
       *****************************************************
       #Post#: 2989--------------------------------------------------
       (Abst.) Switching to Ocrevus in RRMS patients at risk of PML pre
       viously treated w/EID Tysabri 
       By: agate Date: August 7, 2020, 6:51 pm
       ---------------------------------------------------------
       From PubMed (August 7, 2020)--"Switching to ocrelizumab in RRMS
       patients at risk of PML previously treated with extended
       interval dosing of natalizumab":
  HTML https://pubmed.ncbi.nlm.nih.gov/32749910/
       *****************************************************